HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stefan Madajewicz Selected Research

3- (4- bromo- 2,6- difluorobenzyloxy)- 5- (3- (4- pyrrolidin- 1- ylbutyl)ureido)isothiazole- 4- carboxylic acid amide

6/2007A phase I/randomized phase II, non-comparative, multicenter, open label trial of CP-547,632 in combination with paclitaxel and carboplatin or paclitaxel and carboplatin alone as first-line treatment for advanced non-small cell lung cancer (NSCLC).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stefan Madajewicz Research Topics

Disease

2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2007 - 09/2006
1Neoplasms (Cancer)
06/2018
1Colorectal Neoplasms (Colorectal Cancer)
04/2012
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2009
1Aortitis
01/2009
1Diarrhea
06/2007
1Exanthema (Rash)
06/2007
1Pleural Effusion (Pleural Effusions)
09/2006

Drug/Important Bio-Agent (IBA)

2GemcitabineFDA Link
04/2012 - 09/2006
2Carboplatin (JM8)FDA LinkGeneric
06/2007 - 09/2006
1Biomarkers (Surrogate Marker)IBA
06/2018
1Leucovorin (Folinic Acid)FDA Link
04/2012
1Bevacizumab (Avastin)FDA Link
04/2012
1Oxaliplatin (Eloxatin)FDA LinkGeneric
04/2012
1Fluorouracil (Carac)FDA LinkGeneric
04/2012
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2009
1Paclitaxel (Taxol)FDA LinkGeneric
06/2007
13- (4- bromo- 2,6- difluorobenzyloxy)- 5- (3- (4- pyrrolidin- 1- ylbutyl)ureido)isothiazole- 4- carboxylic acid amideIBA
06/2007
1sulindac sulfone (exisulind)IBA
09/2006

Therapy/Procedure

2Drug Therapy (Chemotherapy)
06/2007 - 09/2006
1Therapeutics
04/2012